Table 1 Clinical characteristics of study participants with ischemic heart disease

From: Diabetes induces the activation of pro-ageing miR-34a in the heart, but has differential effects on cardiomyocytes and cardiac progenitor cells

 

Study participant ID

Age

Sex

Diabetes duration (years)

Body weight (kg)

Body Mass Index

HbA1C

LVEF (%)

E/A ratio

Non-diabetic

79

56

M

-

82.5

29.6

44

55

0.95

 

85

71

M

-

70.5

24.4

-

30

2.6

 

86

88

F

-

66.5

26.9

45

47

0.58

 

78

64

M

-

76.9

25.4

43

31

4.3

 

83

53

M

-

88

30.5

37

35

0.66

 

88

60

M

-

110

33.2

39

50

N/A

 

89

66

M

-

94.7

28.4

32

68

1.39

 

98

54

F

-

118.3

40.4

35

55

1.48

 

100

83

M

-

68.8

24.7

37

65

0.72

 

104

66

M

-

101

34.9

44

39

1.44

 

106

47

M

-

105

36.3

-

56

1.27

 

107

71

M

-

82

28.5

41

69

1

 

108

69

M

-

108.9

33.3

44

30

N/A

 

110

58

M

-

86.6

30.2

38

57

0.86

 

113

64

M

-

130.2

40.19

41

49

1.62

 

97

72

F

-

80.4

29.9

35

59

3.15

 

127

65

M

-

84

25.925

37

62

0.63

 

139

55

F

-

57.8

22.08

35

59

1.62

Diabetic

84

73

M

8

72.6

25.3

58

73

1.02

 

122

77

F

13

78.7

29.58

43

47

0.48

 

80

57

M

2

98.9

33.8

62

31

3.7

 

82

69

M

5

105.7

34.5

55

30

1.49

 

103

62

M

11

102.4

34.7

74

63

0.98

 

131

66

M

20

83

26.26

57

27

0.48

 

134

68

M

2

93.8

32.15

51

56

0.7

 

92

62

M

4

114.5

36.5

53

57

N/A

 

105

77

M

17

76.11

23.8

86

71

N/A

 

123

83

M

8

63

23.71

49

41

0.62

 

72

70

M

15

77.2

24.4

43

28

1.23

 

111

72

F

4

69.8

25.8

44

65

0.6

 

121

60

M

5

153

49.96

42

62

1.48

 

128

62

F

12

86

31.59

68

82

1.67

 

135

48

M

20

101.6

33.79

79

60

1.3

  1. HbA1c - Glycated haemoglobin; LVEF – left ventricular ejection fraction.